First-in-human study of REGN3767 (R3767), a human LAG-3 monoclonal antibody (mAb), ± cemiplimab in patients (pts) with advanced malignancies.

Kyriakos P. Papadopoulos, Glenn S. Kroog, Derrick Bramble et al.|Journal of Clinical Oncology|2019

Cited by 38